BeyondSpring Inc. Fair Value of Long-Term Debt
BeyondSpring Inc. (BYSI) had Fair Value of Long-Term Debt of $634.00 thousand as of 2021-03-31, per its 6-K filed 2021-06-16.
Discontinued › Notes
us-gaap:LongTermDebtFairValue · last filed 2022-04-14
- 2021-03-31: Long-term Debt, Fair Value $634.00K.
- 2020-12-31: Long-term Debt, Fair Value $2.14M.
- 2020-09-30: Long-term Debt, Fair Value $2.00M.
- 2020-06-30: Long-term Debt, Fair Value $1.93M.
| Period end | Long-term Debt, Fair Value |
|---|---|
| 2021-03-31 | $634.00K 6-K · filed 2021-06-16 |
| 2020-12-31 | $2.14M 20-F · filed 2022-04-14 |
| 2020-09-30 | $2.00M 6-K · filed 2020-11-17 |
| 2020-06-30 | $1.93M 6-K · filed 2020-09-03 |
| 2020-03-31 | $1.21M 6-K · filed 2020-06-11 |
| 2019-12-31 | $1.37M 20-F · filed 2021-04-30 |
| 2019-09-30 | $1.34M 6-K · filed 2019-12-18 |
| 2019-06-30 | $2.83M 6-K · filed 2019-09-18 |
| 2019-03-31 | $2.99M 6-K · filed 2019-07-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |